Examples of using Soliris in English and their translations into Italian
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
-
Official/political
the diseases are considered‘rare', and Soliris was designated an‘orphan medicine'(a medicine used in rare diseases)
In all studies, the dose of Soliris was 600 mg study drug every 7± 2 days for 4 weeks,
In TRIUMPH, study patients treated with Soliris had significantly reduced(p<
Consult your doctor before you take Soliris to be sure that you receive vaccination against Neisseria meningitidis,
Clearance values of Soliris in paediatric aHUS patients were 10.4,
If your child is below the age of vaccination or if you are not vaccinated at least 14 days before you start treatment with Soliris, your doctor will prescribe antibiotics to reduce the risk of infection until 14 days after you have been vaccinated.
other health care provider by infusing a dilution of the Soliris vial from a drip bag through a tube directly into one of your veins.
received Soliris in study M07-005.
Maintenance phase: 1,200 mg of Soliris administered via a 25- 45 minute intravenous infusion for the fifth week, followed by 1,200 mg of Soliris administered via a 25- 45 minute intravenous infusion every 14± 2 days see section 5.1.
will send reminders to prescribers and pharmacists to check if a(re)-vaccination is needed for patients taking Soliris.
The company that makes Soliris will agree the details of a system in each Member State that will ensure that distribution of the medicine only occurs after checking that the patient has been vaccinated appropriately.
Infrequent, low titre antibody responses have been detected in Soliris treated patients across all PNH and non-PNH studies with a frequency(3.4%) similar to that of placebo 4.8.
Formal studies have not been conducted to evaluate the pharmacokinetics of Soliris administration in special patient populations based on gender,
Formal studies have not been conducted to evaluate the pharmacokinetics of Soliris administration in special PNH patient populations based on gender,
When Soliris treatment was continued for more than 26 weeks, one additional patient(68% of patients in total)
When Soliris treatment was continued for more than 26 weeks, three additional patients(63% of patients in total)
The effectiveness of Soliris treatment was assessed using a range of measurements,
The median duration of Soliris therapy was 16 weeks(range 4 to 70 weeks)
Alexion received FDA approval of Soliris(eculizumab, an injectable complement inhibitor)
Additionally, all patients must be vaccinated against meningococcus at least 2 weeks prior to receiving Soliris unless the risk of delaying Soliris therapy outweigh the risks of developing a meningococcal infection.